ArticlePloS one2024

Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation.

Awwad A Radwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.